Should I Buy CELU? CELU 2026 Analysis

Should You Buy Celularity Inc (CELU) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

1.300

1 Day change

11.11%

52 Week Range

4.350

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and price is sitting on/just below near-term support (S1 ~1.206).
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.
Options positioning is call-heavy, but the extremely high IV suggests a speculative, high-risk setup rather than a clean upside entry.
With earnings on 2026-02-12 (after hours) and no supportive momentum signal today, the risk/reward for an impatient entry is unfavorable.

Technical Analysis

Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), implying the primary trend is down.
Momentum: MACD histogram is positive (0.00945) but positively contracting, which often signals weakening upside momentum/possible stall.
RSI_6 at 38.631: weak/soft demand (not oversold enough to imply a strong bounce signal).
Key levels: Pivot 1.267 (needs reclaim for a more constructive bias). Immediate support S1 1.206 then S2 1.169; resistance R1 1.329 then R2 1.366.
Near-term pattern read: Similar-pattern stats suggest ~flat next day (-0.01%) but positive skew over 1 week (+3.83%) and 1 month (+6.2%); however, the current MA structure argues any bounce is still counter-trend unless price reclaims the pivot.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Very call-skewed open interest (call OI 2147 vs put OI 284), typically read as bullish/speculative interest.
Activity: Today’s volume 41 vs 5D avg 13 and 10D avg 9.7 (elevated activity), but put volume is 0, reinforcing one-sided speculation.
Volatility: IV_30d ~290.34% with IV percentile 85.6 (extremely elevated). This often means options are pricing big moves and can reflect event risk or distressed/speculative trading rather than “healthy” bullish conviction.

Technical Summary

Sell

Buy

Positive Catalysts

- Potential technical bounce setup if price holds ~1.206 and reclaims pivot ~1.267 (would improve near-term bias).
- Earnings catalyst: next earnings on 2026-02-12 after hours (could trigger a sharp move given very high implied volatility).
- Options market is strongly call-skewed (OI put-call ratio 0.13), suggesting some traders are positioned for upside.

Neutral/Negative Catalysts

- Dominant trend remains bearish (MA stack) and MACD upside momentum is fading (histogram contracting).
- Very high implied volatility (~290%) signals elevated uncertainty; moves can be violent, and pricing implies the market expects turbulence.
- No supportive news flow in the last week to justify a momentum reversal.
- Support risk: trading around S1 (~1.206); a break increases downside odds toward ~1.169.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 5.284M, -43.16% YoY (material contraction).
Gross margin: 19, -64.94% YoY (profitability deterioration).
Net income: -23.076M, improved +43.35% YoY, but still deeply negative (loss-making).
EPS: -0.88, improved +20.55% YoY, but still negative; overall picture is “losses narrowing while top-line and margin weaken.”

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating / price target change data was provided in the dataset, so a recent Wall Street upgrade/downgrade trend cannot be confirmed.
Wall Street pros/cons view (inferred only from provided fundamentals/market signals):
- Pros: call-heavy options positioning; potential catalyst from upcoming earnings.
- Cons: sharp YoY revenue decline and margin compression; bearish technical trend; no proprietary buy signals today.
Influential/political trading: No recent congress trading data available; hedge fund and insider trends are neutral with no significant recent activity noted.

Analyst Rating

Wall Street analysts forecast CELU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELU is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.170

Low

Averages

High

Current: 1.170

Low

Averages

High

CELU Should I Buy

CELU Should I Buy

Should You Buy Celularity Inc (CELU) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data

People Also Watch